aPTT (Activated Partial Thromboplastin Time)
🩸 aPTT (Activated Partial Thromboplastin Time) — Complete Guide
A core laboratory test for evaluating intrinsic & common coagulation pathways
The activated Partial Thromboplastin Time (aPTT) is one of the most essential coagulation tests. It assesses whether the intrinsic and common coagulation pathways are functioning properly and is crucial in evaluating bleeding tendencies, coagulation factor deficiencies, heparin therapy, and suspected DIC.
1. What Is aPTT?
aPTT measures the time (in seconds) required for plasma to clot after activation of the intrinsic pathway.
It evaluates the functional activity of the following coagulation factors:
- Intrinsic pathway: VIII, IX, XI, XII
- Common pathway: II, V, X, fibrinogen
Therefore, aPTT is essential in the evaluation of:
- Hemophilia A (Factor VIII deficiency)
- Hemophilia B (Factor IX deficiency)
- Coagulation factor inhibitors
- Unfractionated heparin (UFH) therapy
- Disseminated intravascular coagulation (DIC)
2. Purpose of the Test
✔ 1) Identify Causes of Bleeding
- Congenital factor deficiencies (VIII, IX, XI, XII)
- Acquired inhibitors (e.g., Factor VIII inhibitor)
- Coagulation factor consumption (DIC)
✔ 2) Monitor Anticoagulant Therapy
- Standard test for UFH monitoring
- Prolonged with direct thrombin inhibitors (argatroban, dabigatran)
✔ 3) Pre-operative Bleeding Risk Assessment
✔ 4) Screening Test for Lupus Anticoagulant (LA)
3. Test Principle (Clot-Based Assay)
🔬 How the test works
4
- Blood is collected in 3.2% sodium citrate tubes and plasma is separated.
- Plasma is incubated with:
- Phospholipid
- Activator (silica, kaolin, ellagic acid)
These activate the intrinsic coagulation pathway.
- Calcium chloride (CaCl₂) is added to initiate clotting.
- The instrument measures the time to fibrin clot formation → aPTT (seconds)
⮕ If coagulation factors are deficient or inhibited, aPTT becomes prolonged.
4. Reference Range
Typical reference range:
▶ 25–42 seconds
However, this varies depending on:
- Analyzer and reagent
- Local laboratory validation
Each laboratory should report its own validated reference interval.
5. Clinical Significance of Prolonged aPTT
🩸 1) Coagulation Factor Deficiencies
- Hemophilia A (Factor VIII)
- Hemophilia B (Factor IX)
- Factor XI or XII deficiency
- Common pathway factors (II, V, X, fibrinogen)
🩸 2) Anticoagulant Effects
- UFH (unfractionated heparin) — major cause
- Direct thrombin inhibitors (argatroban, dabigatran)
🩸 3) Lupus Anticoagulant (LA)
Paradoxically:
- aPTT prolongs
- But thrombosis risk increases
🩸 4) Liver Disease
Reduced synthesis of coagulation factors
🩸 5) DIC
Consumption of clotting factors → prolonged PT & aPTT
🩸 6) Other
- Vitamin K deficiency (mild effect)
- Dilutional coagulopathy after massive transfusion
6. Clinical Significance of Shortened aPTT
Short aPTT is uncommon but may indicate:
▶ Hypercoagulable states
- Acute inflammation
- Tissue injury
- Malignancy
▶ Technical issues
- Inadequate citrate volume
- Incorrect blood-to-anticoagulant ratio
7. How to Interpret aPTT Results
✔ 1) Normal PT + Prolonged aPTT
Suggests intrinsic pathway abnormality:
- Hemophilia A/B
- Factor XI deficiency
- Lupus anticoagulant
- UFH effect
✔ 2) Prolonged PT + Prolonged aPTT
Suggests common pathway abnormality:
- Liver failure
- DIC
- Vitamin K deficiency
- DOAC effect
8. Mixing Test: Essential Follow-up When aPTT Is Prolonged
A 1:1 mixing study differentiates factor deficiency from inhibitor presence.
| Mixing Test Result | Interpretation |
|---|---|
| Corrected | Suggests factor deficiency |
| Not corrected | Suggests inhibitors (LA, factor VIII inhibitor) |
9. Important Considerations
⚠ 1) Sensitive to Pre-Analytical Errors
- Wrong citrate ratio (must be 9:1)
- Hemolysis, lipemia
- Clotted specimen
⚠ 2) Always check medication history
- UFH
- DOACs
⚠ 3) Pregnancy decreases aPTT slightly
⚠ 4) Evaluate together with PT, fibrinogen, D-dimer
✔ Summary
- aPTT evaluates intrinsic + common coagulation pathways.
- Useful for diagnosing bleeding disorders, monitoring UFH, and evaluating DIC.
- Prolonged aPTT suggests factor deficiency, inhibitor presence, LA, anticoagulants, or DIC.
- Mixing test distinguishes deficiency vs inhibitor.
- Interpretation must consider pre-analytical and medication factors.
📚 References
- CLSI. One-Stage Prothrombin Time (PT) and Activated Partial Thromboplastin Time (aPTT) Guidelines.
- Rodak BF. Hematology: Clinical Principles and Applications. Elsevier.
- Henry JB. Clinical Diagnosis and Management by Laboratory Methods.
- Triplett DA. “Coagulation and Bleeding Disorders.” Clin Chem.
- Laposata M. Coagulation Disorders. NEJM Review.
- WHO. Hematology and Coagulation Laboratory Guidelines.